Printer Friendly
The Free Library
14,679,458 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Hi-Tech Pharmacal reports FDA ANDA approvals for two generic drugs to aid in chronic constipation.


AMITYVILLE, N.Y.--(BUSINESS WIRE)--July 10, 1995--Bernard Seltzer, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Hi-Tech Pharmacal Co. Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:HITK) today announced FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approvals of Abbreviated New Drug Applications (ANDA's) of two forms of Lactulose lactulose /lac·tu·lose/ (lak´tu-los) a synthetic disaccharide used as a laxative and to enhance excretion or formation of ammonia in the treatment of hepatic encephalopathy.  Solution USP, the generic equivalents of Chronulac and Cephulac, both by Marion Merrell Dow Inc.

"With industry brand sales in excess of $3 million and generic sales of Lactulose Solution USP in excess of $6 million and growing, we have an opportunity to generate significant revenue and income from these new products" Seltzer commented. "We are also pleased to note that these approvals represent our fourth and fifth ANDA approvals in a little over eight months and expect that new approval trend to continue. Hi-Tech currently has 20 ANDA applications on file with the FDA."

Hi-Tech Pharmacal Co. Inc. manufactures more than 100 prescription and over-the-counter generic and branded pharmaceuticals in liquid and semi-solid (creams, ointments, suppositories suppositories,
n.pl solid capsules made of materials that melt at body temperature and are used to deliver medicinal substances into the rectum.
 and gels) dosage forms, primarily for the private label market. The company also manufactures and markets its own products under the name of H-T as well as Sooth-it brand and Diabetic Tussin brand products through its Health Care Products Division.

CONTACT: Hi-Tech Pharmacal Co. Inc.

Bernard Seltzer

David Seltzer

516/789-8228

or

H.L. Lanzet Inc.

Herbert Lanzet

Paul Holm

212/687-0061
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 10, 1995
Words:213
Previous Article:Brandolini and Kunz named co-heads of London International Equity Sales.
Next Article:ENZON AND SCHERING CORPORATION REVISE WORLDWIDE AGREEMENT FOR PEG-INTRON A.
Topics:



Related Articles
Hi-Tech Pharmacal reports FDA and ANDA approval for generic drug used in treatment of seizures; FDA approval is company's third in 90-day period.
Hi-Tech Pharmacal signs letter-of-intent to supply Genpharm of Canada with version of inhalation solution for asthma sufferers.
Hi-Tech Pharmacal receives sixth ANDA approval in eight months; receives ANDA approval for LIDOCAINE 2% SOL. USP.
Hi-Tech Pharmacal reports record sales and earnings for fiscal 1995 ended April 30, 1995.
Caraco anticipates ANDA approvals.
Hi-Tech Pharmacal receives FDA approval to market generic form of phenergan with dextromethorphan syrup.
Hi-Tech Pharmacal reports higher first quarter sales.
Hi-Tech Pharmacal Receives FDA Approval to Market Generic Form of Phenergan with Codeine Phosphate Syrup.
FDA APPROVES TEVA'S ANDA TO MARKET GENERIC VERSION OF ZOCOR.
Boca Pharmacal Receives FDA Approval for Generic Version of Panlor(R)SS.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles